Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Ribbon Communications
RBBN
$372M
| $1.6M | ﹤0.01% |
407,139
+11,451
| +3% | +$41.6K |
|
2777
Vanguard Russell 2000 ETF
VTWO
$17.6B
| $1.6M | ﹤0.01% |
27,758
+11,066
| +66% | +$585K |
|
2778
iShares New York Muni Bond ETF
NYF
$1.41B
| $1.6M | ﹤0.01% |
27,802
-132,514
| -83% | -$7.49M |
|
|
CCRD
2779
DELISTED
CoreCard
CCRD
| $1.6M | ﹤0.01% |
46,831
+3,087
| +7% | +$103K |
|
2780
argenx
ARGX
$53B
| $1.59M | ﹤0.01% |
7,075
+37
| +0.5% | +$6.57K |
|
2781
Ooma
OOMA
$572M
| $1.59M | ﹤0.01% |
96,749
+8,016
| +9% | +$100K |
|
2782
Liquidity Services
LQDT
$1.36B
| $1.59M | ﹤0.01% |
267,194
+3,005
| +1% | +$15.9K |
|
|
SYRS
2783
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.59M | ﹤0.01% |
14,905
+3,229
| +28% | +$290K |
|
|
LKFT
2784
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $1.59M | ﹤0.01% |
8,040
+5,047
| +169% | +$1.05M |
|
2785
Beazer Homes USA
BZH
$872M
| $1.58M | ﹤0.01% |
157,322
-21,655
| -12% | -$173K |
|
2786
SI-BONE Inc
SIBN
$848M
| $1.57M | ﹤0.01% |
98,729
+37,641
| +62% | +$593K |
|
|
RST
2787
DELISTED
ROSETTA STONE INC
RST
| $1.57M | ﹤0.01% |
93,326
+6,059
| +7% | +$102K |
|
|
CNR
2788
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $1.57M | ﹤0.01% |
259,392
-35,473
| -12% | -$181K |
|
|
BSX.PRA
2789
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $1.57M | ﹤0.01% |
+15,000
| New | +$1.61M |
|
2790
Brookfield Infrastructure Partners
BIP
$18.3B
| $1.57M | ﹤0.01% |
57,248
-1,653
| -3% | -$44.1K |
|
2791
Farmers & Merchants Bancorp
FMAO
$486M
| $1.56M | ﹤0.01% |
73,668
-3,908
| -5% | -$86.3K |
|
|
ECOM
2792
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $1.56M | ﹤0.01% |
98,645
+3,348
| +4% | +$38.7K |
|
2793
Puma Biotechnology
PBYI
$453M
| $1.56M | ﹤0.01% |
149,550
-21,047
| -12% | -$218K |
|
2794
Alerus Financial
ALRS
$837M
| $1.56M | ﹤0.01% |
78,870
+31,506
| +67% | +$568K |
|
|
EBTC
2795
DELISTED
Enterprise Bancorp
EBTC
| $1.56M | ﹤0.01% |
65,308
-5,120
| -7% | -$119K |
|
2796
Napco Security Technologies
NSSC
$1.36B
| $1.55M | ﹤0.01% |
132,676
-4,388
| -3% | -$46K |
|
2797
Oppenheimer Holdings
OPY
$1.23B
| $1.55M | ﹤0.01% |
71,126
-6,281
| -8% | -$127K |
|
|
TBNK
2798
DELISTED
Territorial Bancorp Inc.
TBNK
| $1.55M | ﹤0.01% |
65,103
-438
| -0.7% | -$10.8K |
|
2799
Ducommun
DCO
$3.12B
| $1.55M | ﹤0.01% |
44,403
-248
| -0.6% | -$7.34K |
|
2800
Cytosorbents Corp
CTSO
$24.3M
| $1.54M | ﹤0.01% |
155,760
-3,214
| -2% | -$29.5K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.